IRIS Institutional Research Information System - OPENBS Open Archive UniBS

METRA, MARCO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 61.045
EU - Europa 33.415
AS - Asia 17.589
AF - Africa 127
SA - Sud America 94
Continente sconosciuto - Info sul continente non disponibili 77
OC - Oceania 77
AN - Antartide 1
Totale 112.425
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 60.868
UA - Ucraina 10.683
CN - Cina 10.374
IT - Italia 5.071
DE - Germania 4.097
PL - Polonia 3.454
HK - Hong Kong 3.323
FI - Finlandia 2.301
SG - Singapore 1.952
IE - Irlanda 1.918
RU - Federazione Russa 1.905
GB - Regno Unito 1.712
FR - Francia 1.169
IN - India 1.143
SE - Svezia 597
TR - Turchia 309
CA - Canada 149
VN - Vietnam 129
QA - Qatar 114
BE - Belgio 112
CZ - Repubblica Ceca 106
MU - Mauritius 84
EU - Europa 76
NL - Olanda 73
AU - Australia 70
ES - Italia 41
BR - Brasile 40
JP - Giappone 40
KR - Corea 39
RO - Romania 37
IR - Iran 36
ID - Indonesia 24
CH - Svizzera 18
PH - Filippine 15
CL - Cile 14
SA - Arabia Saudita 14
EG - Egitto 13
GR - Grecia 13
AT - Austria 12
MX - Messico 12
PK - Pakistan 12
CO - Colombia 11
HU - Ungheria 11
TH - Thailandia 11
AL - Albania 10
AR - Argentina 10
SK - Slovacchia (Repubblica Slovacca) 10
MK - Macedonia 9
BG - Bulgaria 7
EE - Estonia 7
LU - Lussemburgo 7
NZ - Nuova Zelanda 7
PE - Perù 7
TN - Tunisia 7
ZA - Sudafrica 7
IQ - Iraq 6
KZ - Kazakistan 6
LV - Lettonia 6
PA - Panama 6
PT - Portogallo 6
SI - Slovenia 6
VE - Venezuela 6
AE - Emirati Arabi Uniti 5
AZ - Azerbaigian 5
LA - Repubblica Popolare Democratica del Laos 5
MA - Marocco 5
IL - Israele 4
TW - Taiwan 4
UG - Uganda 4
UZ - Uzbekistan 4
DK - Danimarca 3
JO - Giordania 3
LK - Sri Lanka 3
MY - Malesia 3
NO - Norvegia 3
RS - Serbia 3
BA - Bosnia-Erzegovina 2
BD - Bangladesh 2
BS - Bahamas 2
CI - Costa d'Avorio 2
CR - Costa Rica 2
DZ - Algeria 2
EC - Ecuador 2
ET - Etiopia 2
FK - Isole Falkland (Malvinas) 2
HR - Croazia 2
IS - Islanda 2
KW - Kuwait 2
UY - Uruguay 2
A1 - Anonimo 1
BZ - Belize 1
CY - Cipro 1
GS - Georgia del Sud e Isole Sandwich Australi 1
HN - Honduras 1
HT - Haiti 1
IM - Isola di Man 1
JM - Giamaica 1
KE - Kenya 1
KG - Kirghizistan 1
MD - Moldavia 1
Totale 112.423
Salva come PNG Salva come JPEG
Città #
Fairfield 8.125
Jacksonville 7.990
Woodbridge 6.023
Ashburn 4.151
Houston 4.117
Chandler 4.081
Cambridge 3.588
Princeton 3.516
Warsaw 3.428
Wilmington 3.420
Hong Kong 3.308
Ann Arbor 3.254
Seattle 3.039
Nanjing 2.750
Dublin 1.904
Moscow 1.771
Beijing 1.537
New York 1.327
Singapore 1.140
Nanchang 1.033
Helsinki 995
Des Moines 802
Hebei 661
Shenyang 658
Changsha 538
Milan 512
San Diego 497
Tianjin 468
Jiaxing 446
Brescia 399
Dearborn 375
Jinan 367
Kunming 311
Shanghai 286
Kocaeli 247
Hangzhou 228
Verona 227
Rome 207
London 194
Boardman 153
Lancaster 139
Ningbo 134
Lanzhou 125
Pune 121
Dong Ket 120
Zhengzhou 119
Doha 114
Los Angeles 111
Taizhou 105
Brussels 102
Norwalk 102
San Francisco 101
Haikou 99
Orange 89
Brno 80
Munich 78
Lappeenranta 77
Toronto 77
Changchun 75
Guangzhou 74
Fuzhou 64
Frankfurt am Main 63
Kilburn 61
Florence 60
Taiyuan 57
Washington 53
Saint Petersburg 49
Redwood City 48
Palermo 47
San Mateo 47
Napoli 46
Chicago 33
Augusta 32
Naples 32
Bari 31
Bologna 31
Chiswick 31
Catania 30
Phoenix 27
São Paulo 27
Melbourne 26
Acton 24
Padova 24
Seongnam 23
Trieste 23
Strasbourg 22
Tokyo 22
Hefei 21
Leawood 21
Olomouc 21
Prescot 21
Westminster 21
Canberra 20
Hanover 20
Ottawa 20
Auburn Hills 19
Caserta 19
North York 19
Pavia 19
Torino 19
Totale 81.408
Salva come PNG Salva come JPEG
Nome #
Metabolic exercise test data combined with cardiac and kidney indexes, the MECKI score: A multiparametric approach to heart failure prognosis 1.865
Un caso di Sindrome di Bland-White-Garland: origine anomala dell’arteria coronaria sinistra dall’arteria polmonare. 651
Inodilatatori: perché e quali. 363
American College of Cardiology; American Heart Association Task Force; European Society of Cardiology Committee for Practice Guidelines. ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: a report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Develop Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death). 318
Farmaci inotropi non digitalici. 315
Effect of nesiritide in patients with acute decompensated heart failure. 301
Il genotipo DD per il gene dell’enzima di conversione dell’angiotensina identifica i pazienti con insufficienza cardiaca che possono beneficiare di dosi medio elevate di ACE inibitori. 285
Worsening renal function in patients hospitalised for acute heart failure: Clinical implications and prognostic significance 268
Livelli circolanti del marcatore tumorale CA 125 in pazienti con scompenso cardiaco cronico:relazione con la classe NYHA, i parametri ecocardiografici e variazioni indotte dalla terapia. 257
La cardiomioplastica dinamica come trattamento della cardiomiopatia dilatativa ingravescente. 251
The predictive value of short-term changes in hemoglobin concentration in patients presenting with acute decompensated heart failure 243
Impact of serial troponin release on outcomes in patients with acute heart failure: Analysis from the protect pilot study 241
Hemodynamic Predictors of Heart Failure Morbidity and Mortality: Fluid or Flow? 226
Can we improve the treatment of congestion in heart failure? 212
May 2020 at a glance: ischaemic heart failure and sex-related differences 210
Worsening renal function in patients hospitalised for acute heart failure: clinical implications and prognostic significance. 209
Effects of the long-term administration of nebivolol on the clinical symptoms, exercise capacity, and left ventricular function of patients with diastolic dysfunction: results of the ELANDD study. 208
Rolofylline, an adenosine A1-receptor antagonist, in acute heart failure 207
Is worsening renal function an ominous prognostic sign in patients with acute heart failure? The role of congestion and its interaction with renal function. 206
I polimorfismi Arg16Gly del gene recettore beta-2 adrenergico influenzano i parametri emodinamici e la prognosi dei pazienti con insufficienza cardiaca 206
Role of beta1- and alpha2c-adrenergic receptor polymorphisms and their combination in heart failure: a case-control study 203
Acute heart failure: multiple clinical profiles and mechanisms require tailored therapy. 201
Old and new intravenous inotropic agents in the treatment of advanced heart failure 201
Comparison of carvedilol and metoprolol on clinical outcomes in patients with chronic heart failure in the Carvedilol Or Metoprolol European Trial (COMET): randomised controlled trial 198
Guidelines on the management of valvular heart disease: The Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology. 196
Assessing and grading congestion in acute heart failure: a scientific statement from the acute heart failure committee of the heart failure association of the European society of cardiology and endorsed by the European society of intensive care medicine 194
Early dyspnoea relief in acute heart failure: prevalence, association with mortality, and effect of rolofylline in the PROTECT Study 193
I polimorfismi Arg16 Gly del gene recettore beta-2 adrenergico influenzano i parametri emodinamici e la prognosi dei pazienti con insufficienza cardiaca. 192
Highlights of the 2009 scientific sessions of the European Society of Cardiology. 190
Should beta-blocker therapy be reduced or withdrawn after an episode of decompensated heart failure? Results from COMET. 188
Troponin I in acute decompensated heart failure: insights from the ASCEND-HF study 187
Troponin T levels in patients with acute heart failure : clinical and prognostic significance of their delection and release during hospitalisation 186
Correction to: Tocilizumab for patients with COVID-19 pneumonia. The single-arm TOCIVID-19 prospective trial 186
Postdischarge assessment after a heart failure hospitalization: the next step forward. 185
L’ indice di performance miocardica ( MPI ) è un importante indicatore prognostico nei pazienti affetti da insufficienza cardiaca cronica. 183
Influence of heart rate, blood pressure, and beta-blocker dose on outcome and the differences in outcome between carvedilol and metoprolol tartrate in patients with chronic heart failure: results from the COMET trial. 183
Early drop in systolic blood pressure and worsening renal function in acute heart failure: renal results of Pre-RELAX-AHF. 178
Nebivolol: haemodynamic effects and clinical significance of combined beta-blockade and nitric oxide release. 164
Task Force sullo Scompenso Cardiaco Acuto della Societa Europea di Cardiologia. Versione italiana a cura di A Gavazzi, M Metra. Riassunto esecutivo delle linee guida sulla diagnosi e trattamento dello scompenso cardiaco acuto. 159
Effect of serelaxin on cardiac, renal, and hepatic biomarkers in the Relaxin in Acute Heart Failure (RELAX-AHF) development program: correlation with outcomes. 159
Use of inotropic agents in patients with advanced heart failure: lessons from recent trials and hopes for new agents. 154
Determinazione dell’equilibrio simpato-vagale attraverso l’analisi spettrale della variabilità della frequenza cardiaca in pazienti con insufficienza cardiaca di diverso grado di severità. 150
Beta-blocker treatment of patients with diastolic heart failure and arterial hypertension. A prospective, randomized, comparison of the long-term effects of atenolol vs. nebivolol. 148
Efficacia di un nuovo diuretico, la muzolimina, in pazienti con insufficienza cardiaca. 147
Characteristics and mid-term follow-up of a single-center population affected by Tako-Tsubo cardiomyopathy 147
Effectiveness of MitraClip therapy in patients with refractory heart failure 147
The role of n-3 PUFAs in preventing the arrhythmic risk in patients with idiopathic dilated cardiomyopathy. 145
Multiparametric prognostic scores in chronic heart failure with reduced ejection fraction: A long-term comparison 145
Advanced chronic heart failure: A position statement from the Study Group on Advanced Heart Failure of the Heart Failure Association of the European Societyof Cardiology 143
Effects of the Adenosine A(1) Receptor Antagonist Rolofylline on Renal Function in Patients With Acute Heart Failure an Renal Dysfunction Results From PROTECT (Placebo-Controlled Randomized Study of the Selective A(1) Adenosine ReceptorAntagonist Rolofylline for Patients Hospitalized With Acute Decompensated Heart Failure and Volume Overload to Assess Treatment Effect on Congestion and Renal Function) 143
Effetti cardiovascolari della ventilazione servo-adattativa (ASV) in pazienti affetti da apnee notturne e scompenso cardiaco cronico con disfunzione sistolica ventricolare sinistra 142
Percutaneous edge-to-edge mitral valve repair for the treatment of acute mitral regurgitation complicating myocardial infarction: A single centre experience 142
Effects of tezosentan on symptoms and clinical outcomes in patients with acute heart failure: the VERITAS randomized controlled trials. 141
Fattori di rischio ed “epidemiologia inversa” nei pazienti con insufficienza cardiaca. 140
Self-expanding transcatheter aortic valve implantation for degenerated small Mitroflow bioprosthesis: Early and midterm outcomes 140
Left ventricular reverse remodelling predicts long-term outcomes in patients with functional mitral regurgitation undergoing MitraClip therapy: results from a multicentre registry 140
January 2017 at a glance: oncology, diabetes and antidiabetic treatment, pulmonary hypertension 136
Amino acids and derivatives, a new treatment of chronic heart failure? 135
Mitraclip therapy in patients with functional mitral regurgitation and missing leaflet coaptation: is it still an exclusion criterion? 133
Performance of Prognostic Risk Scores in Chronic Heart Failure Patients Enrolled in the European Society of Cardiology Heart Failure Long-Term Registry 130
Sindromi coronariche acute: ruolo dell’infezione cronica da Helicobacter Pylori e Citomegalovirus. 127
A randomized double-blind crossover study of nicardipine and nifedipine in patients with angina pectoris and concomitant essential hypertension. 126
Effects of ivabradine on endothelial function, aortic properties and ventricular-arterial coupling in chronic systolic heart failure patients 126
A drastic complex atheromatous aorta. A case report. 121
Years-needed-to-treat to add 1 year of life: a new metric to estimate treatment effects in randomized trials. 120
Effects of serelaxin in patients with acute heart failure 120
Systemic lupus erythematosus and endothelial dysfunction: A close relationship 119
Endothelial Dysfunction And Vascular Stiffness In Women With A Previous Pregnancy Complicated By Early Or Late Preeclampsia. 117
Acute heart failure congestion and perfusion status – impact of the clinical classification on in-hospital and long-term outcomes; insights from the ESC-EORP-HFA Heart Failure Long-Term Registry 117
The PROTECT in-hospital risk model: 7-day outcome in patients hospitalized with acute heart failure and renal dysfunction 116
Adrenergic receptor gene polymorphism and left ventricular reverse remodelling after cardiac resynchronization therapy: preliminary results 116
n-3 PUFAs and cardiovascular disease prevention. 116
Prognostic Value of Serial Clinical, Laboratory and Ecocardiographic Tests in Ambulatory Patients with Chronic Heart Failure 115
Nutritional Supplementation with Amino Acids in Ambulatory Patients with Idiophatic Dilatated Cardiomyophaty 115
The puzzle of kidney dysfunction in heart failure: an introduction. 114
Are Beta-1 and alpha2c-adrenergic receptor polymorphisms associated with an increased risk of heart failure in Caucasian subjects: results of a case-control study 114
Effect of High dose of atorvastatin versus moderate dose on endothelial function and inflammatory biomarkers in patients with STEMI 114
Acute and chronic effects of the dihydropyridine calcium antagonist nisoldipine on the resting and exercise hemodynamics, neurohumoral parameters, and functional capacity of patients with chronic heart failure. 112
Consistent survival benefit of carvedilol over metoprolol irrespective of baseline characteristics of heart failure patients – Mode of death evaluation in COMET. 112
A case of iatrogenic severe mitral regurgitation 112
Insights into cardiac alterations after pre-eclampsia: an echocardiographic study. 112
Clinical Presentation and Outcome in a Contemporary Cohort of Patients with Acute Myocarditis: The Multicenter Lombardy Registry 112
Acute hemodynamic effects of the two dopaminergic agonists ibopamine and dihydroergotamine, a comparison with the parent compound. 111
Neurohormonal activation in acute heart failure: results from VERITAS 111
Effects of aldosterone blockers on left ventricular function and remodeling in patients with mild-moderate chronic heart failure. 110
Raised homocystein plasma concentration in patients with heart failure: Clinical significance 110
Effects of spironolactone on ventricular-arterial coupling in patients with chronic systolic heart failure and mild symptoms 110
Clinical relevance and management of the major electrolyte abnormalities in congestive heart failure: hyponatremia, hypokalemia, and hypomagnesemia. 109
Is there a rationale for antiplatelet therapy in acute heart failure? 109
Elastic aortic properties in patients with X syndrome 109
Prognostic role of β-blocker selectivity and dosage regimens in heart failure patients. Insights from the MECKI score database 109
Endothelial Dysfunction In Early Systemic Lupus Erythematosus Patients And Controls Without Previous Cardiovascular Events. 109
Effects of alirocumab on cardiovascular and metabolic outcomes after acute coronary syndrome in patients with or without diabetes: a prespecified analysis of the ODYSSEY OUTCOMES randomised controlled trial 109
Angiotensin-converting-enzyme gene polymorphism and heart failure: a case-control study. 108
The role of plasma biomarkers in acute heart failure. Serial changes and independent prognostic value of NT-proBNP and cardiac troponin-T 108
The management of acute heart failure. 108
An unusual case of myocardial infarction 108
Mechanism of cardiovascular toxicity by proteasome inhibitors: new paradigm derived from clinical and pre-clinical evidence 108
March 2019 at a glance: epidemiology and clinical trials 108
A rationale for the use of BETA-blockers as standard treatment for heart failure 107
Totale 18.150
Salva come PNG Salva come JPEG
Categoria #
all - tutte 611.061
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 611.061
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202024.128 0 801 966 3.301 1.384 3.237 2.347 3.233 1.866 3.631 1.227 2.135
2020/202121.566 480 2.632 518 2.690 725 2.661 1.092 2.659 3.206 2.019 2.169 715
2021/202211.535 453 2.282 230 767 247 621 378 983 646 1.315 1.114 2.499
2022/202312.162 1.998 252 133 995 1.079 3.565 47 1.195 1.745 107 505 541
2023/202412.883 753 279 743 838 525 1.819 462 472 3.497 340 749 2.406
2024/20251.390 984 406 0 0 0 0 0 0 0 0 0 0
Totale 114.281